MSB 2.17% $1.13 mesoblast limited

rexlemestrocel-L in the treatment of chronic low back pain (CLBP), page-25

  1. 489 Posts.
    lightbulb Created with Sketch. 251
    No it’s not the same thing. The grey area wording from MSB has causes many investors large loses. It’s time for more transparency from SI and co. We’re are all left guessing most of the time.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.